[1]
“Postbiotic driven immunomodulation: SCFAs as therapeutic agents in rheumatoid arthritis”, J Curr Biomed Rep, vol. 4, no. 4, pp. 141–142, Dec. 2023, doi: 10.61882/jcbior.4.4.292.